2016年ietls雅思阅读模拟试题（10）_第2页

　　7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug,

　　called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. "The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL," says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

　　(613 words nature)

　　Questions 1-7

　　This passage has 7 paragraphs 1-7.

　　Choose the correct heading for each paragraph from the list of headings below. Write the correct number i-ix in boxes 1-7 on your answer sheet.

　　List of Headings

　　i. How does torcetrapib work?

　　ii. Contradictory result prior to the current trial

　　iii. One failure may possibly bring about future success

　　iv. The failure doesn’t lead to total loss of confidence

　　v. It is the right route to follow

　　vi. Why it’s stopped

　　vii. They may combine and theoretically produce ideal result

　　viii. What’s wrong with the drug

　　ix. It might be wrong at the first place

　　Example answer

　　Paragraph 1 iv

　　1. Paragraph 2

　　2. Paragraph 3

　　3. Paragraph 4

　　4. Paragraph 5

　　5. Paragraph 6

　　6. Paragraph 7